Key result
K-ras mutations appear in ~60% of primary cardiac sarcomas with no p53 mutations observed.
Why the study?
Mutational status of K-ras and TP53 genes in primary cardiac sarcomas was investigated to understand their genetic alterations.
What is the mutational status of K-ras and TP53 genes in primary sarcomas of the heart?
Observational (n=7)
Yes
What is the mutational status of K-ras and TP53 genes in primary sarcomas of the heart?
K-ras mutations at codon 13 may be present in primary cardiac sarcomas, including both angiosarcomas and rhabdomyosarcomas, while p53 mutations appear absent in this small series.
No takes yet. Share an insight, caveat, or question.
May support K-ras profiling in cardiac sarcomas; leaves open diagnostic or therapeutic roles pending larger validation.
García et al. (2000) conducted an observational in Primary sarcomas of the heart (n=7). K-ras and TP53 gene mutations was evaluated on Frequency of p53 and K-ras mutations. Among 5 patients with primary cardiac sarcomas, K-ras mutations at codon 13 were detected in 60% (3 of 5) of cases, while no p53 mutations were observed.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: